Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NURO

NeuroMetrix (NURO) Stock Price, News & Analysis

NeuroMetrix logo

About NeuroMetrix Stock (NASDAQ:NURO)

Advanced Chart

Key Stats

Today's Range
$4.33
$4.69
50-Day Range
$4.55
$4.55
52-Week Range
$2.66
$4.73
Volume
35,522 shs
Average Volume
17,104 shs
Market Capitalization
$9.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NURO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroMetrix and its competitors with MarketBeat's FREE daily newsletter.

NURO Stock News Headlines

The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Neurometrix Announces Board Changes for 2024
NeuroMetrix announces Bradley Fluegel to resign from Board
See More Headlines

NURO Stock Analysis - Frequently Asked Questions

NeuroMetrix, Inc. (NASDAQ:NURO) released its earnings results on Tuesday, November, 5th. The medical device company reported ($0.75) earnings per share (EPS) for the quarter. The medical device company had revenue of $0.59 million for the quarter. NeuroMetrix had a negative trailing twelve-month return on equity of 42.56% and a negative net margin of 203.71%.

Shares of NeuroMetrix reverse split on the morning of Wednesday, November 22nd 2023.The 1-8 reverse split was announced on Monday, November 20th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroMetrix investors own include AMC Entertainment (AMC), NIO (NIO), Digital World Acquisition (DWAC), Meta Platforms (META), Advanced Micro Devices (AMD), Pfizer (PFE) and Tesla (TSLA).

Company Calendar

Last Earnings
11/05/2024
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NURO
CIK
1289850
Employees
20
Year Founded
1996

Profitability

EPS (Trailing Twelve Months)
($4.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.53 million
Net Margins
-203.71%
Pretax Margin
-203.69%
Return on Equity
-42.56%
Return on Assets
-39.26%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
13.88
Quick Ratio
12.70

Sales & Book Value

Annual Sales
$3.03 million
Price / Sales
3.09
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$13.18 per share
Price / Book
0.35

Miscellaneous

Outstanding Shares
2,060,000
Free Float
1,903,000
Market Cap
$9.37 million
Optionable
Not Optionable
Beta
1.82

Social Links

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:NURO) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners